Exane Derivatives’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$42.1K Sell
210
-218
-51% -$51.1K 0.02% 324
2022
Q1
$129K Sell
428
-8
-2% -$2.34K 0.04% 432
2021
Q4
$157K Sell
436
-335
-43% -$115K 0.04% 382
2021
Q3
$255K Sell
771
-27
-3% -$9.07K 0.06% 330
2021
Q2
$254K Sell
798
-186
-19% -$52.2K 0.06% 334
2021
Q1
$242K Sell
984
-762
-44% -$192K 0.07% 270
2020
Q4
$476K Sell
1,746
-249
-12% -$61.8K 0.14% 169
2020
Q3
$472K Sell
1,995
-39
-2% -$8.76K 0.14% 139
2020
Q2
$386K Buy
2,034
+1,638
+414% +$294K 0.1% 172
2020
Q1
$65.4K Sell
396
-96
-20% -$17.6K 0.02% 333
2019
Q4
$97.9K Hold
492
0.02% 317
2019
Q3
$88.5K Hold
492
0.02% 325
2019
Q2
$86K Hold
492
0.02% 344
2019
Q1
$93.5K Buy
492
+249
+102% +$44.3K 0.02% 300
2018
Q4
$38.8K Buy
+243
New +$41.2K 0.01% 387

Other funds holding ISRG

Exane Derivatives's ISRG Position: Q2 2022 in Review

Exane Derivatives reduced its Intuitive Surgical (ISRG) stake by 51% in Q2 2022, selling an estimated $51.1K and leaving 210 shares worth $42.1K. The position accounts for 0.02% of the portfolio, ranked #324.

Exane Derivatives first reported a position in ISRG in Q4 2018 and has held it in 15 quarters since. The position peaked at $476K in Q4 2020. 1,325 funds tracked by Wall St. Rank hold ISRG as of Q2 2022.

  • Exane Derivatives held 210 shares of Intuitive Surgical worth $42.1K as of Q2 2022.
  • Exane Derivatives sold 218 Intuitive Surgical shares in Q2 2022, an estimated $51.1K.
  • Intuitive Surgical made up 0.02% of Exane Derivatives's portfolio in Q2 2022, its #324 holding.
  • Exane Derivatives first reported a position in Intuitive Surgical in Q4 2018 and has held it in 15 quarters since.
  • Exane Derivatives's Intuitive Surgical position peaked at $476K in Q4 2020.
  • 1,325 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.